See more : Oscar Properties Holding AB (publ) (OP.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Lonza Group AG (0QNO.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lonza Group AG, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Fusen Pharmaceutical Company Limited (1652.HK) Income Statement Analysis – Financial Results
- Cariloha, Inc. (ALOHA) Income Statement Analysis – Financial Results
- Bryah Resources Limited (BYH.AX) Income Statement Analysis – Financial Results
- Rockwool A/S (ROCK-B.CO) Income Statement Analysis – Financial Results
- Roadside Real Estate plc (BAKBF) Income Statement Analysis – Financial Results
Lonza Group AG (0QNO.L)
About Lonza Group AG
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and nutrition markets in Switzerland and internationally. It operates through Biologics, Small Molecules, Cell and Gene, and Capsules and Health Ingredients divisions. The Biologics division engages in the contract development and manufacturing services for biopharmaceuticals. The Small Molecules division operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. The Cell and Gene division develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies. It also offers contract development and manufacturing services for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment provides specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules and Health Ingredients division offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group Ltd was founded in 1897 and is headquartered in Basel, Switzerland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.72B | 6.22B | 5.41B | 4.51B | 4.21B | 5.54B | 4.55B | 4.13B | 3.80B | 3.64B | 3.58B | 3.93B | 2.69B | 2.68B | 2.69B | 2.94B | 2.87B | 2.29B | 2.52B | 2.18B |
| Cost of Revenue | 4.77B | 3.92B | 3.44B | 2.80B | 2.43B | 3.36B | 2.77B | 2.68B | 2.64B | 2.55B | 2.63B | 2.92B | 1.99B | 1.97B | 2.15B | 2.10B | 2.06B | 1.72B | 1.96B | 1.72B |
| Gross Profit | 1.95B | 2.30B | 1.97B | 1.71B | 1.78B | 2.18B | 1.78B | 1.46B | 1.16B | 1.09B | 955.00M | 1.01B | 700.00M | 711.00M | 545.00M | 839.00M | 810.00M | 564.00M | 561.00M | 466.00M |
| Gross Profit Ratio | 29.00% | 36.96% | 36.40% | 37.84% | 42.26% | 39.32% | 39.09% | 35.21% | 30.50% | 29.92% | 26.65% | 25.61% | 26.00% | 26.53% | 20.26% | 28.57% | 28.22% | 24.68% | 22.25% | 21.36% |
| Research & Development | 105.00M | 95.00M | 90.00M | 78.00M | 177.00M | 204.00M | 145.00M | 151.00M | 192.00M | 202.00M | 226.00M | 116.00M | 94.00M | 99.00M | 103.00M | 110.00M | 89.00M | 70.00M | 63.00M | 72.00M |
| General & Administrative | 600.00M | 721.00M | 671.00M | 603.00M | 600.00M | 678.00M | 554.00M | 451.00M | 297.00M | 280.00M | 201.00M | 299.00M | 205.00M | 152.00M | 166.00M | 189.00M | 64.00M | 43.00M | 49.00M | 45.00M |
| Selling & Marketing | 237.00M | 244.00M | 224.00M | 235.00M | 201.00M | 344.00M | 277.00M | 281.00M | 239.00M | 239.00M | 228.00M | 245.00M | 160.00M | 155.00M | 144.00M | 135.00M | 130.00M | 87.00M | 75.00M | 71.00M |
| SG&A | 837.00M | 827.00M | 760.00M | 687.00M | 804.00M | 1.03B | 831.00M | 732.00M | 536.00M | 519.00M | 429.00M | 544.00M | 365.00M | 307.00M | 310.00M | 324.00M | 194.00M | 130.00M | 124.00M | 116.00M |
| Other Expenses | 126.00M | -29.00M | -300.00M | -4.00M | 2.00M | -27.00M | -28.00M | -49.00M | -71.00M | -62.00M | -65.00M | -52.00M | -20.00M | -69.00M | -107.00M | 91.00M | -18.00M | -4.00M | -4.00M | 67.00M |
| Operating Expenses | 1.07B | 951.00M | 1.15B | 769.00M | 999.00M | 1.28B | 1.15B | 1.01B | 743.00M | 743.00M | 748.00M | 670.00M | 439.00M | 337.00M | 306.00M | 398.00M | 402.00M | 263.00M | 264.00M | 255.00M |
| Cost & Expenses | 5.84B | 4.87B | 4.59B | 3.57B | 3.43B | 4.64B | 3.92B | 3.69B | 3.39B | 3.29B | 3.38B | 3.59B | 2.43B | 2.31B | 2.45B | 2.50B | 2.46B | 1.98B | 2.22B | 1.97B |
| Interest Income | 30.00M | 6.00M | 3.00M | 3.00M | 60.00M | 94.00M | 94.00M | 73.00M | 76.00M | 67.00M | 102.00M | 6.00M | 18.00M | 6.00M | 10.00M | 32.00M | 19.00M | 14.00M | 23.00M | 12.00M |
| Interest Expense | 93.00M | 73.00M | 72.00M | 71.00M | 84.00M | 101.00M | 130.00M | 85.00M | 80.00M | 76.00M | 108.00M | 102.00M | 91.00M | 49.00M | 63.00M | 88.00M | 72.00M | 55.00M | 67.00M | 36.00M |
| Depreciation & Amortization | 621.00M | 596.00M | 522.00M | 526.00M | 544.00M | 526.00M | 411.00M | 307.00M | 283.00M | 286.00M | 287.00M | 304.00M | 276.00M | 273.00M | 278.00M | 250.00M | 251.00M | 213.00M | 188.00M | 173.00M |
| EBITDA | 1.53B | 2.12B | 1.38B | 1.39B | 1.35B | 1.43B | 1.07B | 766.00M | 781.00M | 732.00M | 696.00M | 651.00M | 513.00M | 644.00M | 518.00M | 807.00M | 684.00M | 494.00M | 499.00M | 388.00M |
| EBITDA Ratio | 22.81% | 31.26% | 24.79% | 32.45% | 31.54% | 26.78% | 26.54% | 22.19% | 20.54% | 20.11% | 19.42% | 15.97% | 20.13% | 24.33% | 19.59% | 27.68% | 23.83% | 22.71% | 19.79% | 17.55% |
| Operating Income | 880.00M | 1.35B | 819.00M | 937.00M | 918.00M | 1.01B | 821.00M | 617.00M | 498.00M | 446.00M | 409.00M | 335.00M | 261.00M | 374.00M | 239.00M | 441.00M | 408.00M | 301.00M | 297.00M | 211.00M |
| Operating Income Ratio | 13.10% | 21.68% | 15.14% | 20.79% | 21.82% | 18.22% | 18.05% | 14.93% | 13.09% | 12.25% | 11.41% | 8.54% | 9.70% | 13.96% | 8.88% | 15.02% | 14.22% | 13.17% | 11.78% | 9.67% |
| Total Other Income/Expenses | -90.00M | -93.00M | -91.00M | -98.00M | -106.00M | -35.00M | -138.00M | -113.00M | -87.00M | -144.00M | -148.00M | -111.00M | -86.00M | -43.00M | -53.00M | 34.00M | -47.00M | -50.00M | -53.00M | -32.00M |
| Income Before Tax | 790.00M | 1.45B | 788.00M | 789.00M | 719.00M | 807.00M | 535.00M | 373.00M | 341.00M | 279.00M | 105.00M | 221.00M | 175.00M | 330.00M | 186.00M | 475.00M | 361.00M | 251.00M | 244.00M | 179.00M |
| Income Before Tax Ratio | 11.76% | 23.24% | 14.57% | 17.50% | 17.09% | 14.56% | 11.76% | 9.03% | 8.97% | 7.66% | 2.93% | 5.63% | 6.50% | 12.31% | 6.91% | 16.17% | 12.58% | 10.98% | 9.68% | 8.20% |
| Income Tax Expense | 135.00M | 230.00M | 83.00M | 53.00M | 71.00M | 148.00M | 131.00M | 72.00M | 64.00M | 42.00M | 18.00M | 39.00M | 21.00M | 46.00M | 27.00M | 56.00M | 60.00M | 52.00M | 56.00M | 41.00M |
| Net Income | 654.00M | 1.22B | 2.94B | 869.00M | 645.00M | 559.00M | 726.00M | 301.00M | 277.00M | 237.00M | 87.00M | 182.00M | 154.00M | 284.00M | 159.00M | 419.00M | 301.00M | 222.00M | 188.00M | 138.00M |
| Net Income Ratio | 9.74% | 19.52% | 54.43% | 19.28% | 15.33% | 10.09% | 15.96% | 7.28% | 7.28% | 6.51% | 2.43% | 4.64% | 5.72% | 10.60% | 5.91% | 14.27% | 10.49% | 9.72% | 7.46% | 6.32% |
| EPS | 8.88 | 16.37 | 39.65 | 11.68 | 8.73 | 7.51 | 9.78 | 5.73 | 5.30 | 4.56 | 1.67 | 3.11 | 2.76 | 5.14 | 2.95 | 8.16 | 5.86 | 4.34 | 3.68 | 2.70 |
| EPS Diluted | 8.88 | 16.34 | 39.52 | 11.63 | 8.68 | 7.48 | 9.70 | 5.69 | 5.26 | 4.54 | 1.67 | 3.10 | 2.75 | 5.12 | 2.94 | 7.55 | 5.45 | 3.98 | 3.58 | 2.70 |
| Weighted Avg Shares Out | 73.63M | 74.23M | 74.26M | 74.40M | 74.11M | 74.41M | 67.88M | 52.87M | 52.66M | 52.19M | 52.10M | 55.90M | 55.74M | 56.58M | 54.81M | 56.91M | 56.97M | 58.99M | 51.15M | 51.15M |
| Weighted Avg Shares Out (Dil) | 73.68M | 74.36M | 74.49M | 74.71M | 74.56M | 74.72M | 68.46M | 52.87M | 52.69M | 52.19M | 52.16M | 56.12M | 55.98M | 56.83M | 55.21M | 56.91M | 56.97M | 58.99M | 53.70M | 51.15M |
Source: https://incomestatements.info
Category: Stock Reports